MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock and...
$9,899K
Maturities of marketable
securities
$2,000K
Net cash provided by
financing activities
$9,899K
Net cash provided by
(used in) investing...
$1,858K
Canceled cashflow
$142K
Net (decrease)
increase in cash and cash...
-$16,358K
Canceled cashflow
$11,757K
Accounts payable
$7,739K
Accrued expenses and
other liabilities
$7,190K
Stock-based compensation
expense
$2,349K
Prepaid expenses and
other current assets
-$1,135K
Lease liability
$1,134K
Depreciation and
amortization
$465K
Non-cash lease expense
$83K
Loss on disposal of
property and equipment
-$8K
Other
-$1K
Purchases of property and
equipment
$142K
Net cash used in
operating activities
-$28,115K
Canceled cashflow
$20,104K
Net loss
-$47,652K
Deposit and other
long-term assets
$551K
Net accretion of
discount on marketable...
$16K
Back
Back
Cash Flow
source: myfinsight.com
Adverum Biotechnologies, Inc. (ADVM)
Adverum Biotechnologies, Inc. (ADVM)